Abstract
Introduction
Aspirin-intolerant asthma (AIA), a major clinical presentation of aspirin hypersensitivity, affects 10% of adult asthmatics. The genetic risk factors involved in the susceptibility to AIA have recently been investigated, but multilocus single-nucleotide polymorphisms (SNPs) associated with this susceptibility has not been evaluated.
Methods
We examined 246 asthmatic patients: 94 having aspirin intolerance and 152 having aspirin tolerance. We selected 23 SNPs of 13 candidate genes and genotyped each SNP using a primer extension method. Multilocus genetic interactions were examined using multifactor dimensionality reduction (MDR) to test all multilocus SNP combinations to identify a useful SNP set for predicting the AIA phenotype.
Results
We identified the best model using the MDR method, which consisted of a four-locus gene–gene interaction with 65.16% balanced accuracy and a cross-validation consistency of 70% in predicting AIA disease risk among asthmatic patients. This model included four SNPs such as B2ADR 46A>G, CCR3–520T>G, CysLTR1–634C>T, and FCER1B–109T>C.
Discussion
These results suggest that a multilocus SNP acts in combination to influence the susceptibility to aspirin intolerance in asthmatics and could be a useful genetic marker for the diagnosis of AIA.
Abbreviations
- AIA:
-
aspirin-intolerant asthma
- ATA:
-
aspirin-tolerant asthma
- ALOX5:
-
arachidonate 5-lipoxygenase
- B2ADR:
-
adrenergic, beta-2-, receptor, surface
- CCR3:
-
chemokine (C-C motif) receptor 3
- CysLTR1:
-
cysteinyl leukotriene receptor 1
- CysLTR2:
-
cysteinyl leukotriene receptor 2
- FCER1B:
-
Fc fragment of IgE, high affinity I, receptor for; beta polypeptide
- IL10:
-
interleukin 10
- IL13:
-
interleukin 13
- IL18:
-
interleukin 18
- LTC4S:
-
leukotriene C4 synthase
- NSAID:
-
nonsteroidal antiinflammatory drug
- SNP:
-
single-nucleotide polymorphism
- TBXA2R:
-
thromboxane A2 receptor
- TGFβ1:
-
transforming growth factor, beta 1
- TNFα:
-
tumor necrosis factor alpha
References
Simon RA. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. Curr Allergy Asthma Rep. 2004;4:17–24.
Hamad AM, Sutcliffe AM, Knox AJ. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs. 2004;64:2417–32.
Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434.
Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, et al. Aspirin intolerance and the cyclooxygenase–leukotriene pathways. Curr Opin Pulm Med. 2004;10:51–6.
Picado C. Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes. Allergy. 2002;57:58–60.
Bisgaard H. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy. 2001;56:7–11.
Kim SH, Oh JM, Kim YS, et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy. 2006;36:433–9.
Kim SH, Choi JH, Park HS, et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy. 2005;35:585–90.
Kim SH, Bae JS, Suh CH, et al. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy. 2005;60:760–5.
Kim SH, Ye YM, Lee SK, et al. Association of TNF-alpha genetic polymorphism with HLA DPB1*0301. Clin Exp Allergy. 2006;36:1247–53.
Kim SH, Park HS, Holloway JW, et al. Association between a TGFbeta1 promoter polymorphism and rhinosinusitis in aspirin-intolerant asthmatic patients. Respir Med. 2007;101:490–5.
Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol. 2005;115:963–72.
Litonjua AA. The significance of beta2-adrenergic receptor polymorphisms in asthma. Curr Opin Pulm Med. 2006;12:12–7.
Fukunaga K, Asano K, Mao XQ, et al. Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics. Eur Respir J. 2001;17:59–63.
Chatterjee R, Batra J, Kumar A, et al. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clin Exp Allergy. 2005;35:914–9.
Howard TD, Whittaker PA, Zaiman AL, et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol. 2001;25:377–84.
Higa S, Hirano T, Mayumi M, et al. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy. 2003;33:1097–102.
Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene–gene and gene–environment interactions. Bioinformatics. 2003;19:376–82.
Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene–gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol. 2003;24:150–7.
Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J. 1993;6:391–9.
Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med. 1994;149:940–6.
Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-induced Asthma. Eur Respir J. 2000;16:432–6.
Kim SH, Bae JS, Holloway JW, et al. A polymorphism of MS4A2 (–109T>C) encoding the beta-chain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma. Clin Exp Allergy. 2006;36:877–83.
Szczeklik A, Dworski R, Mastalerz L, et al. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Am J Respir Crit Care Med. 1998;158:1168–72.
Paganin F, Poubeau P, Yvin JL, et al. The effectiveness of leukotriene antagonists in the treatment of aspirin-intolerant asthmatic patients. Presse Med. 2003;32:978–84. (In French).
Park HW, Shin ES, Lee JE, et al. Multilocus analysis of atopy in Korean children using multifactor-dimensionality reduction. Thorax. 2007;62:265–9.
Semik A, Barczyk A, Pierzchala W. Provocation tests in the diagnosis of acetylsalicylic acid intolerance. Wiad Lek. 2005;58:543–8.
Kowalski ML, Ptasinska A, Jedrzejczak M, et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-sensitive Patients Identification Test (ASPITest). Allergy. 2005;60:1139–45.
Acknowledgements
This study was supported by grants from the Basic Research Program of the Korea Science and Engineering Foundation (R01-2006-000-10775-0) and the Korea Health 21 R&D Project of the Ministry of Health and Welfare, Republic of Korea (A050571).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, SH., Jeong, HH., Cho, BY. et al. Association of Four-locus Gene Interaction with Aspirin-intolerant Asthma in Korean Asthmatics. J Clin Immunol 28, 336–342 (2008). https://doi.org/10.1007/s10875-008-9190-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-008-9190-7